Paul K S Chan Selected Research

SARS-CoV-2 spike protein

3/2022	Mucosal Antibody Response to SARS-CoV-2 in Paediatric and Adult Patients: A Longitudinal Study.
1/2021	Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul K S Chan Research Topics

Disease

51	Infections 09/2023 - 06/2002
47	Human Influenza (Influenza) 08/2023 - 01/2007
29	Neoplasms (Cancer) 04/2024 - 01/2002
16	COVID-19 01/2023 - 01/2020
16	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 10/2002
15	Severe Acute Respiratory Syndrome 04/2010 - 12/2003
8	Pneumonia (Pneumonitis) 01/2020 - 05/2008
7	Papillomavirus Infections 12/2022 - 11/2005
7	Uterine Cervical Dysplasia 06/2011 - 11/2005
6	Hepatitis B 01/2018 - 03/2004
6	Hepatitis 06/2007 - 08/2003
5	Carcinogenesis 09/2023 - 01/2002
5	Inflammation (Inflammations) 12/2022 - 01/2017
5	Critical Illness (Critically Ill) 01/2022 - 04/2010
5	Fever (Fevers) 01/2011 - 12/2004
4	Squamous Cell Carcinoma of Head and Neck 12/2022 - 05/2016
4	Respiratory Insufficiency (Respiratory Failure) 12/2021 - 11/2012
4	Clostridium Infections 09/2020 - 01/2018
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019 - 07/2005
4	Influenza in Birds (Avian Flu) 11/2012 - 03/2008
3	Dengue (Dengue Fever) 01/2018 - 06/2006
3	Warts (Wart) 01/2016 - 02/2009
3	Gastroenteritis 03/2014 - 08/2006
3	Nasopharyngeal Carcinoma 05/2013 - 08/2005
3	Virus Diseases (Viral Diseases) 03/2010 - 08/2004
3	Carcinoma (Carcinomatosis) 10/2009 - 07/2005
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2007 - 09/2006
2	Coronavirus Infections 12/2022 - 07/2005
2	Dysbiosis 05/2022 - 10/2018
2	Communicable Diseases (Infectious Diseases) 05/2022 - 01/2016
2	Hemorrhage 01/2022 - 12/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2022
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 04/2004
2	Shock 01/2020 - 12/2008
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2018 - 10/2008
2	Papilloma (Papillomatosis) 01/2016 - 07/2014
2	Chickenpox 09/2015 - 05/2004
2	Adenocarcinoma 08/2015 - 08/2012
2	Asthma (Bronchial Asthma) 02/2010 - 08/2009
2	Lymphoma (Lymphomas) 02/2009 - 03/2004
2	Breast Neoplasms (Breast Cancer) 12/2004 - 08/2003
1	Autoimmune Diseases (Autoimmune Disease) 01/2023

Drug/Important Bio-Agent (IBA)

33	VaccinesIBA 01/2023 - 10/2002
13	Antiviral Agents (Antivirals)IBA 08/2023 - 02/2003
13	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2002
12	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2002
9	CytokinesIBA 01/2022 - 09/2007
8	Oseltamivir (Tamiflu)FDA Link 08/2023 - 01/2007
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2006
8	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 11/2008
8	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2003
8	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2020 - 10/2009
8	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 12/2004
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 05/2008
6	16S Ribosomal RNAIBA 01/2023 - 12/2019
5	Oxygen (Dioxygen)IBA 09/2023 - 09/2006
5	Oncogene Proteins (Oncogene Protein)IBA 09/2023 - 10/2008
5	AntibodiesIBA 01/2023 - 08/2004
5	Immunoglobulin G (IgG)IBA 01/2023 - 07/2005
5	AntigensIBA 01/2019 - 03/2004
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 08/2003
5	Viral RNAIBA 02/2014 - 09/2004
4	SteroidsIBA 08/2023 - 08/2004
4	Messenger RNA (mRNA)IBA 01/2023 - 11/2013
4	InterferonsIBA 01/2023 - 06/2002
4	C-Reactive ProteinIBA 12/2022 - 07/2005
4	Neuraminidase (Sialidase)IBA 12/2021 - 07/2008
3	Hemagglutinins (Hemagglutinin)IBA 12/2021 - 07/2008
3	EnzymesIBA 01/2016 - 09/2010
3	Peptides (Polypeptides)IBA 12/2013 - 09/2010
3	Amino Acids FDA Link 12/2013 - 04/2009
3	ChemokinesIBA 12/2011 - 11/2010
3	Lamivudine (Epivir)FDA Link 08/2005 - 03/2004
2	COVID-19 VaccinesIBA 01/2023 - 01/2022
2	Neutralizing AntibodiesIBA 01/2023 - 12/2020
2	Immunoglobulin A (IgA)IBA 01/2023 - 03/2022
2	BNT162 VaccineIBA 01/2023 - 01/2023
2	SARS-CoV-2 spike proteinIBA 03/2022 - 01/2021
2	Polysaccharides (Glycans)IBA 01/2020 - 02/2003
2	Therapeutic UsesIBA 12/2019 - 11/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018 - 11/2005
2	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 03/2004
2	Rotavirus VaccinesIBA 03/2014 - 04/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2013 - 04/2012
2	Prednisolone (Predate)FDA LinkGeneric 04/2012 - 01/2009
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2009 - 09/2007
2	NeopterinIBA 10/2007 - 07/2005
2	AnthracyclinesIBA 12/2004 - 03/2004
1	Ubiquitin-Specific ProteasesIBA 09/2023
1	nirmatrelvir and ritonavir drug combinationIBA 08/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023

Therapy/Procedure

16	Therapeutics 01/2023 - 01/2002
7	Drug Therapy (Chemotherapy) 02/2009 - 08/2003
4	Fecal Microbiota Transplantation 09/2022 - 10/2018
4	Critical Care (Surgical Intensive Care) 01/2021 - 04/2011
4	Artificial Respiration (Mechanical Ventilation) 01/2021 - 10/2016
3	Transplantation 01/2022 - 01/2018
2	Activities of Daily Living (ADL) 09/2013 - 08/2013
2	Length of Stay 01/2011 - 01/2007
1	Art Therapy 01/2023